Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,509,950
+$1,716,366 QoQ
Shares Held
374,286
+6.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.02626333873027.ToString("F0")%
Shared 0.ToString("F0")%
None 4.973736661269725.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. PFE ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,009,997 | $396,411,608 | |
| 2 | LLY |
ELI LILLY & Co
|
193,029 | $177,542,283 | |
| 3 | AMGN |
Amgen Inc
|
398,069 | $140,060,577 | |
| 4 | ABBV |
AbbVie Inc.
|
430,429 | $93,614,003 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
355,956 | $49,609,587 | |
| 6 | JNJ |
Johnson & Johnson
|
156,815 | $38,331,858 | |
| 7 | PFE |
Pfizer Inc
This page
|
374,286 | $10,509,950 | |
| 8 | NVO |
Novo Nordisk A S
|
155,415 | $5,711,501 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,509,950 | 374,286 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,793,584 | 353,156 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,187,675 | 125,105 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,032,545 | 125,105 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,146,680 | 203,105 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,276,294 | 349,653 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,149,786 | 316,164 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $14,829,679 | 530,010 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,110,097 | 544,508 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,454,460 | 710,471 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,412,938 | 464,665 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,225,104 | 442,342 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,669,060 | 457,575 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,180,924 | 452,399 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $18,661,101 | 426,442 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,843,266 | 912,517 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,309,661 | 991,108 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $13,365,790 | 226,347 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,424,910 | 219,133 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,150,478 | 233,669 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,237,194 | 392,967 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,164,777 | 493,474 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,311,614 | 439,740 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,273,965 | 298,922 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,660,307 | 182,781 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||